Update date: 1 October 2026 | Source: U.S. FDA
At a Glance
- The FDA approved the Autus Size-Adjustable Valve for pediatric patients with congenital pulmonary valve disease.
- It is a surgically implanted pulmonary heart valve.
- The device is designed to be expanded after surgery to keep pace with a child’s growth.
- The FDA describes it as the first U.S.-approved valve of this type and the first U.S.-approved heart valve using polymeric rather than animal-derived leaflet material.
Why the approval is important
Children who require pulmonary valve replacement may otherwise face repeat interventions as they grow. A valve that can be expanded after implantation is intended to reduce the mismatch between a fixed-size prosthesis and a growing child.
What this does not mean
FDA approval in the United States does not automatically establish availability, regulatory approval, reimbursement or standard-of-care status in India. Device selection remains a specialist decision based on anatomy, indication, surgical assessment and local regulatory availability.
Official Source
FDA — First Heart Valve Designed to Grow with Children, 1 October 2026
MedBodh note: This is a regulatory-news summary, not a treatment recommendation.
यह लेख उपयोगी लगा? Share करें